“…3,4 As compared to other species, C. tropicalis depicts various distinct features that increase its intrinsic pathogenicity, 5 including its capability for secretion of extracellular hydrolytic enzymes (coagulase, phospholipase or proteinase), 6,7 biofilm formation 7 and phenotypic switching. 8 In addition, clinical studies have suggested a particular susceptibility to C. tropicalis BSI among neutropenic patients with haematological and solid-organ malignancies. 9e11 Therefore, the outcome of this form of invasive fungal disease is generally assumed to be poorer in comparison to that of BSI due to other Candida species.…”